TrialJournal of the American College of Cardiology2021

Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial.

James L Januzzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.